HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muriel Giansily-Blaizot Selected Research

Factor VII (Proconvertin)

1/2020The EAHAD blood coagulation factor VII variant database.
5/2016Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
4/2013Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
10/2012Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?
8/2007Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.
6/2004Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
4/2002Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muriel Giansily-Blaizot Research Topics

Disease

8Hemorrhage
03/2020 - 04/2002
4Factor VII Deficiency (Hypoproconvertinemia)
05/2016 - 02/2003
3Hemophilia A (Haemophilia)
03/2020 - 05/2016
2Thrombosis (Thrombus)
08/2019 - 10/2012
2Iron Overload
04/2010 - 12/2007
2Epistaxis (Nosebleed)
11/2005 - 04/2002
1Polycythemia (Erythrocytosis)
12/2022
1Hypoxia (Hypoxemia)
12/2022
1Hemolysis
10/2018
1hereditary Xerocytosis
10/2018
1hereditary Hyperferritinemia with congenital cataracts
04/2013
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
10/2012
1Disease Susceptibility (Diathesis)
10/2012
1Hyperferritinemia
12/2007
1beta-Thalassemia (Cooley's Anemia)
12/2007
1type 2 Hemochromatosis
12/2007
1Hemochromatosis (Bronze Diabetes)
12/2007
1Menorrhagia
11/2005
1Contusions
11/2005
1Iron Deficiencies
11/2005
1Hemophilia B (Haemophilia B)
07/2002
1Hemorrhagic Disorders (Hemorrhagic Diathesis)
03/2002

Drug/Important Bio-Agent (IBA)

7Factor VII (Proconvertin)IBA
01/2020 - 04/2002
3Biological ProductsIBA
04/2010 - 04/2002
3factor VII clotting antigenIBA
06/2004 - 03/2002
2beta-Globins (beta Globin)IBA
12/2022 - 12/2007
2Blood Coagulation Factors (Coagulation Factor)IBA
03/2020 - 11/2014
2Factor VIIa (Activated Factor VII)IBA
12/2017 - 05/2016
2AntibodiesIBA
05/2016 - 07/2002
25' Untranslated Regions (5' UTR)IBA
04/2013 - 12/2007
2Peptides (Polypeptides)IBA
12/2007 - 07/2002
1Hemoglobins (Hemoglobin)IBA
12/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2022
1Oxygen (Dioxygen)IBA
12/2022
1ThrombinFDA Link
08/2019
1IronIBA
10/2018
1recombinant FVIIa (rFVIIa)FDA Link
12/2017
1ApoferritinsIBA
04/2013
1CoagulantsIBA
10/2012
1Ferritins (Ferritin)IBA
12/2007
1HepcidinsIBA
12/2007
1Transferrin Receptors (Transferrin Receptor)IBA
12/2007
1Antimicrobial PeptidesIBA
12/2007
1Transferrin (beta 2 Transferrin)IBA
12/2007
1metal transporting protein 1 (ferroportin)IBA
12/2007
1Hemostatics (Antihemorrhagics)IBA
06/2004
1Nonsense Codon (Nonsense Mutation)IBA
02/2003

Therapy/Procedure

4Therapeutics
11/2014 - 04/2002
2Minor Surgical Procedures (Minor Surgery)
11/2005 - 04/2002
1Operative Surgical Procedures
10/2012